NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

Let's expand logically from your thought:

After recent failed attempt by NWBO to purchase a facility in Germany (per quarterly report), I suspect that is where NWBO might hunt for new deal on next manu facil.

Remaining DNDN facilities are domiciled in US NOT EUROPE! where GBM mfg needs would appear to lead that of current US PH3.

MOREOVER isn't one of the key requirements of PIE: vaccine mfg in Germany??

Complicated by the fact that the initial disclosure by NWBO occurred in the June '14 10Q filed Aug! meaning because NWBO is so understaffed and LP apparently does quadruple type duties the 10Q is her catch all instead of
a press release.

For all we know that Leipiz facility may still be in active negotiations or others have taken it's place.